Global And China Plasma Protein Therapeutics Market Insights, Forecast To 2027

1 Study Coverage
1.1 Plasma Protein Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Type
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Application
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Plasma Protein Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Plasma Protein Therapeutics Revenue 2016-2027
2.1.2 Global Plasma Protein Therapeutics Sales 2016-2027
2.2 Global Plasma Protein Therapeutics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Plasma Protein Therapeutics Historical Market Size by Region (2016-2021)
2.3.1 Global Plasma Protein Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Plasma Protein Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Plasma Protein Therapeutics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Plasma Protein Therapeutics Sales Forecast by Region (2022-2027)
2.4.2 Global Plasma Protein Therapeutics Revenue Forecast by Region (2022-2027)

3 Global Plasma Protein Therapeutics Competitor Landscape by Players
3.1 Global Top Plasma Protein Therapeutics Manufacturers by Sales
3.1.1 Global Plasma Protein Therapeutics Sales by Manufacturer (2016-2021)
3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Plasma Protein Therapeutics Manufacturers by Revenue
3.2.1 Key Plasma Protein Therapeutics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Plasma Protein Therapeutics Revenue by Manufacturers (2016-2021)
3.2.3 Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Plasma Protein Therapeutics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Plasma Protein Therapeutics Revenue in 2020
3.2.6 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Plasma Protein Therapeutics Price by Manufacturers
3.4 Global Plasma Protein Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Plasma Protein Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Plasma Protein Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Plasma Protein Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Plasma Protein Therapeutics Market Size by Type (2016-2021)
4.1.1 Global Plasma Protein Therapeutics Sales by Type (2016-2021)
4.1.2 Global Plasma Protein Therapeutics Revenue by Type (2016-2021)
4.1.3 Plasma Protein Therapeutics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Plasma Protein Therapeutics Market Size Forecast by Type (2022-2027)
4.2.1 Global Plasma Protein Therapeutics Sales Forecast by Type (2022-2027)
4.2.2 Global Plasma Protein Therapeutics Revenue Forecast by Type (2022-2027)
4.2.3 Plasma Protein Therapeutics Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Plasma Protein Therapeutics Market Size by Application (2016-2021)
5.1.1 Global Plasma Protein Therapeutics Sales by Application (2016-2021)
5.1.2 Global Plasma Protein Therapeutics Revenue by Application (2016-2021)
5.1.3 Plasma Protein Therapeutics Price by Application (2016-2021)
5.2 Plasma Protein Therapeutics Market Size Forecast by Application (2022-2027)
5.2.1 Global Plasma Protein Therapeutics Sales Forecast by Application (2022-2027)
5.2.2 Global Plasma Protein Therapeutics Revenue Forecast by Application (2022-2027)
5.2.3 Global Plasma Protein Therapeutics Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Plasma Protein Therapeutics Market Size YoY Growth 2016-2027
6.1.1 China Plasma Protein Therapeutics Sales YoY Growth 2016-2027
6.1.2 China Plasma Protein Therapeutics Revenue YoY Growth 2016-2027
6.1.3 China Plasma Protein Therapeutics Market Share in Global Market 2016-2027
6.2 China Plasma Protein Therapeutics Market Size by Players (International and Local Players)
6.2.1 China Top Plasma Protein Therapeutics Players by Sales (2016-2021)
6.2.2 China Top Plasma Protein Therapeutics Players by Revenue (2016-2021)
6.3 China Plasma Protein Therapeutics Historic Market Review by Type (2016-2021)
6.3.1 China Plasma Protein Therapeutics Sales Market Share by Type (2016-2021)
6.3.2 China Plasma Protein Therapeutics Revenue Market Share by Type (2016-2021)
6.3.3 China Plasma Protein Therapeutics Price by Type (2016-2021)
6.4 China Plasma Protein Therapeutics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Plasma Protein Therapeutics Sales Forecast by Type (2022-2027)
6.4.2 China Plasma Protein Therapeutics Revenue Forecast by Type (2022-2027)
6.4.3 China Plasma Protein Therapeutics Price Forecast by Type (2022-2027)
6.5 China Plasma Protein Therapeutics Historic Market Review by Application (2016-2021)
6.5.1 China Plasma Protein Therapeutics Sales Market Share by Application (2016-2021)
6.5.2 China Plasma Protein Therapeutics Revenue Market Share by Application (2016-2021)
6.5.3 China Plasma Protein Therapeutics Price by Application (2016-2021)
6.6 China Plasma Protein Therapeutics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Plasma Protein Therapeutics Sales Forecast by Application (2022-2027)
6.6.2 China Plasma Protein Therapeutics Revenue Forecast by Application (2022-2027)
6.6.3 China Plasma Protein Therapeutics Price Forecast by Application (2022-2027)

7 North America
7.1 North America Plasma Protein Therapeutics Market Size YoY Growth 2016-2027
7.2 North America Plasma Protein Therapeutics Market Facts & Figures by Country
7.2.1 North America Plasma Protein Therapeutics Sales by Country (2016-2021)
7.2.2 North America Plasma Protein Therapeutics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Plasma Protein Therapeutics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Plasma Protein Therapeutics Market Facts & Figures by Region
8.2.1 Asia Pacific Plasma Protein Therapeutics Sales by Region (2016-2021)
8.2.2 Asia Pacific Plasma Protein Therapeutics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Plasma Protein Therapeutics Market Size YoY Growth 2016-2027
9.2 Europe Plasma Protein Therapeutics Market Facts & Figures by Country
9.2.1 Europe Plasma Protein Therapeutics Sales by Country (2016-2021)
9.2.2 Europe Plasma Protein Therapeutics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Plasma Protein Therapeutics Market Size YoY Growth 2016-2027
10.2 Latin America Plasma Protein Therapeutics Market Facts & Figures by Country
10.2.1 Latin America Plasma Protein Therapeutics Sales by Country (2016-2021)
10.2.2 Latin America Plasma Protein Therapeutics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Plasma Protein Therapeutics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Plasma Protein Therapeutics Market Facts & Figures by Country
11.2.1 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Shire (Baxalta)
12.1.1 Shire (Baxalta) Corporation Information
12.1.2 Shire (Baxalta) Description and Business Overview
12.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shire (Baxalta) Plasma Protein Therapeutics Products Offered
12.1.5 Shire (Baxalta) Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Description and Business Overview
12.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CSL Plasma Protein Therapeutics Products Offered
12.2.5 CSL Recent Development
12.3 Grifols
12.3.1 Grifols Corporation Information
12.3.2 Grifols Description and Business Overview
12.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Grifols Plasma Protein Therapeutics Products Offered
12.3.5 Grifols Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Description and Business Overview
12.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Octapharma Plasma Protein Therapeutics Products Offered
12.4.5 Octapharma Recent Development
12.5 Kedrion
12.5.1 Kedrion Corporation Information
12.5.2 Kedrion Description and Business Overview
12.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kedrion Plasma Protein Therapeutics Products Offered
12.5.5 Kedrion Recent Development
12.6 LFB Group
12.6.1 LFB Group Corporation Information
12.6.2 LFB Group Description and Business Overview
12.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 LFB Group Plasma Protein Therapeutics Products Offered
12.6.5 LFB Group Recent Development
12.7 Biotest
12.7.1 Biotest Corporation Information
12.7.2 Biotest Description and Business Overview
12.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Biotest Plasma Protein Therapeutics Products Offered
12.7.5 Biotest Recent Development
12.8 BPL
12.8.1 BPL Corporation Information
12.8.2 BPL Description and Business Overview
12.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 BPL Plasma Protein Therapeutics Products Offered
12.8.5 BPL Recent Development
12.9 RAAS
12.9.1 RAAS Corporation Information
12.9.2 RAAS Description and Business Overview
12.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 RAAS Plasma Protein Therapeutics Products Offered
12.9.5 RAAS Recent Development
12.10 CBPO
12.10.1 CBPO Corporation Information
12.10.2 CBPO Description and Business Overview
12.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CBPO Plasma Protein Therapeutics Products Offered
12.10.5 CBPO Recent Development
12.11 Shire (Baxalta)
12.11.1 Shire (Baxalta) Corporation Information
12.11.2 Shire (Baxalta) Description and Business Overview
12.11.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shire (Baxalta) Plasma Protein Therapeutics Products Offered
12.11.5 Shire (Baxalta) Recent Development
12.12 Kamada
12.12.1 Kamada Corporation Information
12.12.2 Kamada Description and Business Overview
12.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Kamada Products Offered
12.12.5 Kamada Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Plasma Protein Therapeutics Industry Trends
13.2 Plasma Protein Therapeutics Market Drivers
13.3 Plasma Protein Therapeutics Market Challenges
13.4 Plasma Protein Therapeutics Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Plasma Protein Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Plasma Protein Therapeutics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor
Table 3. Major Manufacturers of Immune Globulin
Table 4. Major Manufacturers of Albumin
Table 5. Major Manufacturers of Others
Table 6. Global Plasma Protein Therapeutics Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Plasma Protein Therapeutics Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Plasma Protein Therapeutics Sales by Regions (2016-2021) & (K Units)
Table 9. Global Plasma Protein Therapeutics Sales Market Share by Regions (2016-2021)
Table 10. Global Plasma Protein Therapeutics Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Plasma Protein Therapeutics Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Plasma Protein Therapeutics Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Plasma Protein Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Plasma Protein Therapeutics Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Plasma Protein Therapeutics Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Plasma Protein Therapeutics Manufacturers by Revenue (US$ Million) in 2020
Table 18. Plasma Protein Therapeutics Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Plasma Protein Therapeutics Revenue Share by Manufacturers (2016-2021)
Table 20. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Protein Therapeutics as of 2020)
Table 22. Key Manufacturers Plasma Protein Therapeutics Price (2016-2021) (USD/Unit)
Table 23. Plasma Protein Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Plasma Protein Therapeutics Product Type
Table 25. Date of International Manufacturers Enter into Plasma Protein Therapeutics Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasma Protein Therapeutics Sales by Type (2016-2021) (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Share by Type (2016-2021)
Table 29. Global Plasma Protein Therapeutics Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Plasma Protein Therapeutics Revenue Share by Type (2016-2021)
Table 31. Plasma Protein Therapeutics Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 32. Global Plasma Protein Therapeutics Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Plasma Protein Therapeutics Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Plasma Protein Therapeutics Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Plasma Protein Therapeutics Sales by Application (2016-2021) (K Units)
Table 38. Global Plasma Protein Therapeutics Sales Share by Application (2016-2021)
Table 39. Global Plasma Protein Therapeutics Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Plasma Protein Therapeutics Revenue Share by Application (2016-2021)
Table 41. Plasma Protein Therapeutics Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 42. Global Plasma Protein Therapeutics Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Plasma Protein Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Plasma Protein Therapeutics Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 47. China Plasma Protein Therapeutics Sales (K Units) of Key Companies (2016-2021)
Table 48. China Plasma Protein Therapeutics Sales Share by Company (2016-2021)
Table 49. China Plasma Protein Therapeutics Revenue (US$ Million) by Company (2016-2021)
Table 50. China Plasma Protein Therapeutics Revenue Share by Company (2016-2021)
Table 51. China Plasma Protein Therapeutics Sales (K Units) by Type (2016-2021)
Table 52. China Plasma Protein Therapeutics Sales Share by Type (2016-2021)
Table 53. China Plasma Protein Therapeutics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Plasma Protein Therapeutics Price (USD/Unit) by Type (2016-2021)
Table 55. China Plasma Protein Therapeutics Sales (K Units) by Type (2022-2027)
Table 56. China Plasma Protein Therapeutics Sales Share by Type (2022-2027)
Table 57. China Plasma Protein Therapeutics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Plasma Protein Therapeutics Revenue Share by Type (2022-2027)
Table 59. China Plasma Protein Therapeutics Price (USD/Unit) by Type (2022-2027)
Table 60. China Plasma Protein Therapeutics Sales (K Units) by Application (2016-2021)
Table 61. China Plasma Protein Therapeutics Sales Share by Application (2016-2021)
Table 62. China Plasma Protein Therapeutics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Plasma Protein Therapeutics Price (USD/Unit) by Application (2016-2021)
Table 64. China Plasma Protein Therapeutics Sales (K Units) by Application (2022-2027)
Table 65. China Plasma Protein Therapeutics Sales Share by Application (2022-2027)
Table 66. China Plasma Protein Therapeutics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Plasma Protein Therapeutics Revenue Share by Application (2022-2027)
Table 68. China Plasma Protein Therapeutics Price (USD/Unit) by Application (2022-2027)
Table 69. North America Plasma Protein Therapeutics Sales by Country (2016-2021) & (K Units)
Table 70. North America Plasma Protein Therapeutics Sales Market Share by Country (2016-2021)
Table 71. North America Plasma Protein Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Plasma Protein Therapeutics Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Plasma Protein Therapeutics Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Region (2016-2021)
Table 77. Europe Plasma Protein Therapeutics Sales by Country (2016-2021) & (K Units)
Table 78. Europe Plasma Protein Therapeutics Sales Market Share by Country (2016-2021)
Table 79. Europe Plasma Protein Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2016-2021)
Table 81. Latin America Plasma Protein Therapeutics Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Plasma Protein Therapeutics Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Plasma Protein Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Plasma Protein Therapeutics Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Country (2016-2021)
Table 89. Shire (Baxalta) Corporation Information
Table 90. Shire (Baxalta) Description and Business Overview
Table 91. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. Shire (Baxalta) Plasma Protein Therapeutics Product
Table 93. Shire (Baxalta) Recent Development
Table 94. CSL Corporation Information
Table 95. CSL Description and Business Overview
Table 96. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. CSL Product
Table 98. CSL Recent Development
Table 99. Grifols Corporation Information
Table 100. Grifols Description and Business Overview
Table 101. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 102. Grifols Product
Table 103. Grifols Recent Development
Table 104. Octapharma Corporation Information
Table 105. Octapharma Description and Business Overview
Table 106. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 107. Octapharma Product
Table 108. Octapharma Recent Development
Table 109. Kedrion Corporation Information
Table 110. Kedrion Description and Business Overview
Table 111. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 112. Kedrion Product
Table 113. Kedrion Recent Development
Table 114. LFB Group Corporation Information
Table 115. LFB Group Description and Business Overview
Table 116. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. LFB Group Product
Table 118. LFB Group Recent Development
Table 119. Biotest Corporation Information
Table 120. Biotest Description and Business Overview
Table 121. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. Biotest Product
Table 123. Biotest Recent Development
Table 124. BPL Corporation Information
Table 125. BPL Description and Business Overview
Table 126. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. BPL Product
Table 128. BPL Recent Development
Table 129. RAAS Corporation Information
Table 130. RAAS Description and Business Overview
Table 131. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. RAAS Product
Table 133. RAAS Recent Development
Table 134. CBPO Corporation Information
Table 135. CBPO Description and Business Overview
Table 136. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. CBPO Product
Table 138. CBPO Recent Development
Table 139. Hualan Bio Corporation Information
Table 140. Hualan Bio Description and Business Overview
Table 141. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 142. Hualan Bio Product
Table 143. Hualan Bio Recent Development
Table 144. Kamada Corporation Information
Table 145. Kamada Description and Business Overview
Table 146. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Kamada Product
Table 148. Kamada Recent Development
Table 149. Plasma Protein Therapeutics Market Trends
Table 150. Plasma Protein Therapeutics Market Drivers
Table 151. Plasma Protein Therapeutics Market Challenges
Table 152. Plasma Protein Therapeutics Market Restraints
Table 153. Plasma Protein Therapeutics Customers List
Table 154. Plasma Protein Therapeutics Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Protein Therapeutics Product Picture
Figure 2. Global Plasma Protein Therapeutics Sales Market Share by Type in 2020 & 2027
Figure 3. Coagulation Factor Product Picture
Figure 4. Immune Globulin Product Picture
Figure 5. Albumin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Plasma Protein Therapeutics Sales Market Share by Application in 2020 & 2027
Figure 8. Hemophilia
Figure 9. PID
Figure 10. Others
Figure 11. Plasma Protein Therapeutics Report Years Considered
Figure 12. Global Plasma Protein Therapeutics Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Plasma Protein Therapeutics Market Size 2016-2027 (US$ Million)
Figure 14. Global Plasma Protein Therapeutics Sales 2016-2027 (K Units)
Figure 15. Global Plasma Protein Therapeutics Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Plasma Protein Therapeutics Sales Market Share by Region (2016-2021)
Figure 17. Global Plasma Protein Therapeutics Sales Market Share by Region in 2020
Figure 18. Global Plasma Protein Therapeutics Revenue Market Share by Region (2016-2021)
Figure 19. Global Plasma Protein Therapeutics Revenue Market Share by Region in 2020
Figure 20. Global Plasma Protein Therapeutics Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Plasma Protein Therapeutics Revenue in 2020
Figure 22. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Plasma Protein Therapeutics Sales Market Share by Type (2016-2021)
Figure 24. Global Plasma Protein Therapeutics Sales Market Share by Type in 2020
Figure 25. Global Plasma Protein Therapeutics Revenue Market Share by Type (2016-2021)
Figure 26. Global Plasma Protein Therapeutics Revenue Market Share by Type in 2020
Figure 27. Global Plasma Protein Therapeutics Sales Market Share by Application (2016-2021)
Figure 28. Global Plasma Protein Therapeutics Sales Market Share by Application in 2020
Figure 29. Global Plasma Protein Therapeutics Revenue Market Share by Application (2016-2021)
Figure 30. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2020
Figure 31. China Plasma Protein Therapeutics Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Plasma Protein Therapeutics Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Plasma Protein Therapeutics Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Plasma Protein Therapeutics Players Market Share by Revenue in Plasma Protein Therapeutics in 2020
Figure 35. China Plasma Protein Therapeutics Revenue Share by Type (2016-2021)
Figure 36. China Plasma Protein Therapeutics Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Plasma Protein Therapeutics Revenue Share by Application (2016-2021)
Figure 38. China Plasma Protein Therapeutics Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Plasma Protein Therapeutics Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Plasma Protein Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Plasma Protein Therapeutics Sales Market Share by Country in 2020
Figure 42. North America Plasma Protein Therapeutics Revenue Market Share by Country in 2020
Figure 43. U.S. Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Plasma Protein Therapeutics Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Plasma Protein Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2020
Figure 50. Europe Plasma Protein Therapeutics Revenue Market Share by Country in 2020
Figure 51. Germany Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Plasma Protein Therapeutics Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Plasma Protein Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Region in 2020
Figure 64. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Region in 2020
Figure 65. China Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 76. Taiwan Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 84. Philippines Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 86. Vietnam Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Plasma Protein Therapeutics Sales Growth Rate 2016-2021 (K Units)
Figure 88. Latin America Plasma Protein Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Plasma Protein Therapeutics Sales Market Share by Country in 2020
Figure 90. Latin America Plasma Protein Therapeutics Revenue Market Share by Country in 2020
Figure 91. Mexico Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 92. Mexico Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 94. Brazil Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 96. Argentina Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Plasma Protein Therapeutics Sales Growth Rate 2016-2021 (K Units)
Figure 98. Middle East and Africa Plasma Protein Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Country in 2020
Figure 101. Turkey Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 102. Turkey Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 104. Saudi Arabia Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. U.A.E Plasma Protein Therapeutics Sales Growth Rate (2016-2021) (K Units)
Figure 106. U.A.E Plasma Protein Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Plasma Protein Therapeutics Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.